PRESS RELEASE published on 02/12/2026 at 18:00, 4 months 5 days ago THX Pharma to Host a Webinar to Discuss Its Strategic Agreement with Biocodex THX Pharma to host webinar discussing strategic agreement with Biocodex, including licensing terms and development outlook. Webcast on February 17, 6:00 p.m. CET. More info at theranexus.com Webinar Strategic Agreement Neurological Diseases THX Pharma Biocodex
BRIEF published on 02/10/2026 at 18:05, 4 months 7 days ago Strategic agreement between THX Pharma and Biocodex for three rare diseases Rare Diseases License Agreement THX Pharma Biocodex Batten-1 And TX01
BRIEF published on 02/10/2026 at 18:05, 4 months 7 days ago Strategic Licensing Agreement for Rare Disease Treatments Rare Diseases Strategic Agreement Licensing Deal THX Pharma Biocodex
PRESS RELEASE published on 02/10/2026 at 18:00, 4 months 7 days ago THX Pharma and Biocodex announce a strategic licensing agreement covering three rare diseases Biocodex acquires licenses from THX Pharma to develop Batten-1 globally and TX01 in US and Canada. Deal worth up to €173M includes milestone payments and double-digit royalties Batten-1 Licenses TX01 THX Pharma Biocodex
BRIEF published on 01/27/2026 at 18:05, 4 months 21 days ago Theranexus Liquidity Contract Half-Year Review Liquidity Contract PORTZAMPARC Financial Report Theranexus THX Pharma Actions
BRIEF published on 01/20/2026 at 18:05, 4 months 28 days ago THX Pharma Reveals 2026 Financial Schedule Financial Calendar Neurological Diseases Market Communication 2026 Announcements THX Pharma
BRIEF published on 01/20/2026 at 18:05, 4 months 28 days ago THX Pharma unveils its 2026 financial calendar Euronext Paris Financial Agenda Biopharmaceutical 2026 THX Pharma
PRESS RELEASE published on 01/20/2026 at 18:00, 4 months 28 days ago THX Pharma Announces its 2026 Financial Calendar THX Pharma (Theranexus) announces financial communication agenda for 2026, focusing on rare neurological diseases treatments. Company listed on Euronext Growth Paris Euronext Growth Paris Financial Communication Theranexus Neurological Diseases THX Pharma
BRIEF published on 01/08/2026 at 18:05, 5 months 9 days ago Publication of the letter to shareholders by Theranexus Shareholders Neuroscience Rare Diseases Theranexus Drugs
BRIEF published on 01/08/2026 at 18:05, 5 months 9 days ago THX Pharma Releases Shareholder Letter Drug Development Biopharmaceutical Shareholder Communication Neurological Diseases THX Pharma
Published on 06/18/2026 at 11:30, 14 minutes ago Deadline Extended for 2026 Semmelweis-Richter Journalism Award Applications
Published on 06/18/2026 at 00:00, 11 hours 44 minutes ago LIR Life Sciences Completes Comparative Animal Study Showing Successful Protamine-Enhanced Permeation Transport of Both Semaglutide and Tirzepatide
Published on 06/17/2026 at 23:30, 12 hours 14 minutes ago Polaris Renewable Energy Announces Postponement of Annual Meeting of Shareholders
Published on 06/17/2026 at 22:50, 12 hours 54 minutes ago International Battery Metals Ltd. Reports Fourth Quarter and Full Year Fiscal 2026 Financial Results
Published on 06/17/2026 at 22:30, 13 hours 14 minutes ago Innodata Appoints Jayant Chauhan as Chief Financial Officer
Published on 06/18/2026 at 11:30, 14 minutes ago 2026 Climate Transition Barometer: more than one in two European SMEs and mid-caps gain a tangible competitive advantage from decarbonisation (x3 vs. 2023)
Published on 06/18/2026 at 11:00, 44 minutes ago Mallia Aesthetics Reports Positive Results from Consumer Study with its Hormone-Free 8T3 Essentials Hair Serum
Published on 06/18/2026 at 11:00, 44 minutes ago Traum-Ferienwohnungen Launches Vision 360 to Bring AI-Powered Video Tours to Holiday Homeowners Across Europe
Published on 06/18/2026 at 11:00, 44 minutes ago ABB Ltd: ABB share buybacks - June 11, 2026 – June 17, 2026
Published on 06/18/2026 at 09:06, 2 hours 38 minutes ago Eiffage, member of the NSORe joint venture, wins the contract for a converter station for the NSC2 offshore grid connection project in Germany
Published on 06/18/2026 at 08:30, 3 hours 14 minutes ago OPmobility wins first awards with Chinese automaker Leapmotor outside of China
Published on 06/18/2026 at 07:00, 4 hours 44 minutes ago bioMérieux introduces Salmonella testing kit on GENE-UP® TYPER to support root cause analysis in the food industry
Published on 06/17/2026 at 17:40, 18 hours 4 minutes ago Report on share repurchases from 10 to 16 June 2026
Published on 06/17/2026 at 08:45, 1 day 2 hours ago Air Liquide is awarded its largest-ever contract in Spain to care for 90,000 patients living with respiratory conditions at home
